The essential goal of biomedical research is to understand the underlying mechanism of disease development. Unfortunately, achieving this goal requires expensive and time-consuming efforts in medical biotechnology. This review focuses on how context-specific genome-scale metabolic network models may facilitate reaching this goal. Such models provide an in silico framework for computational simulation of cellular metabolism, predicting the outcome of experiments. Therefore, by using these models at the initial stages of experimental design, time and cost in biomedical researches may be reduced. Furthermore, with the availability of such models, not only important pathways involved in cell dysfunction may be better understood, but also drug targets predicted based on these models can be seen as novel targets for in vivo validation. The main point of this review is that metabolic modeling can predict drug targets and biomarkers without the need for kinetics data. We provide a comprehensive review of human metabolic models and their applications, in addition to the methods used for analyzing models. We discuss how these models have been used in analyzing metabolic capabilities of different cells and tissues, in identifying disease-related metabolic pathways and biomarkers, and in understanding the human-microbe interaction.
Introduction
Metabolism, to a large extent, determines the health of cells and so the organism as a whole. Metabolic reprogramming has been shown to occur in many human diseases such as cancer and diabetes [1] . Additionally, there is a growing body of evidence that interactions between host metabolism and the metabolism of human microbiota are associated with the development of obesity, cardiovascular diseases and metabolic syndromes (e.g. diabetes) [2] .
The metabolic network of a cell comprises thousands of interwoven reactions. In this network, extracellular nutrients are consumed to gain energy and to synthesize metabolites as the building blocks of the cell, while the byproduct metabolites are secreted out of the cell. ''Metabolic network reconstruction" is the automatic or manual collection of these reaction data for a certain cell type to make an in silico model of its metabolic activity [3] . To validate such a metabolic network model, one should demonstrate that an acceptable consistency exists between experimental data and the predictions of the computational model [4] . A reliable and carefully-reconstructed metabolic network model may thus provide a virtual laboratory for in silico experimentation in a convenient, cheap and rapid manner [4, 5] . The present article aims to introduce to the readers a comprehensive review of constraint-based human metabolic network models, together with their applications in addressing biomedical problems. In computational systems biomedicine, dynamic models are generally used for modeling metabolism. Here, we emphasize that constraint-based metabolic modeling can be considered as a complementary, powerful framework that can generate predictions about the metabolism of cells in the absence of dynamics or kinetic data of cell systems, even when extensive kinetic data are not available. First, we define the basic concepts which are used for metabolic modeling. Then, after a short review of the history, we describe several examples of human cell-and tissue-specific metabolic models. Finally, we mention some of the biomedical applications of microbial metabolic network models.
Modeling metabolic networks
In a simplified view, a metabolic network is determined by its metabolites and their involved reactions, which are enclosed within a boundary, which typically represents the plasma membrane. Each reaction, which may be reversible or irreversible, connects a set of reactant metabolites to a set of product metabolites with defined stoichiometric coefficients. Fig. 1 schematically represents the constraint-based modeling framework which is used for simulating fluxes in a metabolic network (see Appendix A for further information on the basic concepts in constraint-based modeling).
In a living cell, biomass is composed of certain metabolites with defined ratios. One can use these defined ratios to model the cell growth by addition of an auxiliary biomass producing reaction to the metabolic network. This reaction assembles the precursors of biomass in their defined ratios to form a hypothetical metabolite called ''biomass". This metabolite will be secreted out of the model [6] , in order to avoid its accumulation. The flux of this secretion can be the equivalent of cell growth rate. (See part 1.1.1 and Appendix B for more information).
For a metabolic network with m metabolites and n reactions, the stoichiometric matrix S (Fig. 1B) is a m Â n matrix. In this matrix, element S ij represents the stoichiometric coefficient of metabolite i in reaction j [7] .
The flux of each reaction is the conversion rate of reactants to products during the production of 1 g biomass dry weight. From the theoretical point of view, if the kinetics and the kinetic parameters of all reactions are known, reaction fluxes can be computed deterministically. Such a modeling framework, i.e., ordinary differential equation (ODE) modeling, is especially useful in small-scale networks (for example, see Higgins [8] ; Nolan and Lee [9] ). However, as the size of the network increases, it gets harder to determine all the necessary data for kinetic modeling. If such data are unavailable, kinetic modeling becomes practically infeasible, and one should consider other modeling frameworks for modeling metabolism. Constraint-based modeling of metabolic networks is an appropriate alternative, especially for modeling whole-cell metabolism.
Constraint-based reconstruction and analysis of metabolic networks
Constraint-based modeling (CBM) is a strategy to study fluxes in metabolic networks (see Appendix B). This strategy is particularly useful when extensive data on the kinetics of biochemical reactions are not available. In the CBM framework, by applying thermodynamic, mass balance, and capacity constraints, one may obtain a restricted space of possible flux distributions (Fig. 1C) .
Each point of this constrained area represents a possible flux vector v, in which v i represents the flux of reaction i in the network (Fig. 1D) . Although the exact flux of each reaction in the cell may not be determined in CBM, one can infer general properties of the network by analyzing the flux space. To predict the exact value of each flux, additional assumptions, e.g., the optimality of growth rate, should be considered.
A good example of constraint-based modeling techniques is flux balance analysis (FBA). FBA is a method for determining metabolic fluxes in silico (Fig. 1C) [10] . This method was developed before many other computational techniques in systems biology [11, 12] , but it is still one of the most popular tools for the analysis of metabolic networks. In FBA, fluxes are assumed to satisfy certain constraints, including irreversibility of some reactions (i.e., the thermodynamic constraint), steady-state condition (i.e., the mass balance constraint) and minimum/maximum values for certain fluxes (i.e., the capacity constraint) (see Appendix C). In FBA, by using linear programming, a certain flux vector is determined as the optimal solution. This flux vector maximizes the objective function of the FBA linear program, which is typically biomass production rate.
FBA is routinely used in the analysis of the metabolic networks of bacteria and other unicellular organisms, where biomass production rate is often assumed as the objective function. This assumption is based on the fact that the main goal of a unicellular organism is to rapidly reproduce itself to survive in the presence of competing species. However, the main aim of a human cell may not be just to reproduce itself. Therefore, the objective function in both generic and tissue-specific human models has to be chosen very carefully [13] . While biomass production rate might be an acceptable objective function for modeling cancer cells [14] , for modeling skeletal muscle cells ATP production flux or heme synthesis flux seems more relevant [15] .
Genome-scale metabolic networks: a historical flashback
Haemophilus influenzae, a prokaryote, was the first organism whose genome-scale metabolic network model (GEM) was reconstructed and analyzed [16] . Later, using a GEM of Escherichia coli, an acceptable consistency between experimental and computational results was shown for in vivo and in silico nutrient consumption rates [17] .
To date, hundreds of prokaryotic and eukaryotic GEMs have been reconstructed [18, 19] . These networks can be used to study genotype-phenotype relationships in different species [20, 21] , phenotypes of biotechnologically relevant strains [22, 23] , potential drug targets [24] , and to model genetic and evolutionary relationships of metabolic genes [25] [26] [27] . 2. Human genome-scale metabolic network models
Generic metabolic networks
When the context-specific omics data of an organism is not available, whole genome data can be used to reconstruct generic genome-scale metabolic models. These models can be used to infer the main features of the metabolism of that certain organism and also to study the effects of gene mutations and enzymopathies. A generic genome-scale metabolic network model of the human consists of all currently known enzymatic and spontaneous reactions which may occur in the human body, irrespective of the cell types in which they take place. To date, several human GEMs have been published. HumanCyc [28] was the first human metabolic database formed by mapping genome annotation data to the metabolic pathways. Edinburgh human metabolic network (EHMN) [29] and Recon1 [30] were the first constraint-based genome-scale metabolic models that were released in the same year. Compared to Recon1, EHMN includes more genes and metabolites and also can be linked more easily to other databases. Although, the first version of EHMN does not have any compartments, and therefore, the number of its reactions is less than Recon1 [31] . More precisely, the inclusion of exchange reactions and also the repetition of reactions in different compartments increased the number of reactions of Recon1. Recon1, with 1496 genes, 3748 reactions, and 1469 metabolites, has been the most popular human metabolic model during the last few years. The carefully determined gene-protein-reaction relations of Recon1 can be exploited for modeling pathological conditions and the effect of drugs. That is, by inactivating a gene, and consequently by setting the flux of its corresponding reaction(s) to zero, one may find those reactions that become blocked as a result of a certain mutation. Such an approach successfully modeled the affected reactions in hemolytic anemia and predict the consequences of hypercholesterolemia drugs [30] . In another study, using flux variability analysis (FVA), biomarkers of inborn errors of metabolism were predicted using Recon1 [32] (see Appendix D). The results were in agreement with OMIM [33] and RAMEDIS (Rare metabolic disease) [34] databases.
In 2012, iHuman1512 was released that contains more metabolic genes and reactions than previous models [35] . iHuman1512 can also be linked to omics databases like HPA [36] and HMDB [37] . According to the publication of the second version of Recon1, namely Recon2 [38] , the application of iHuman1512 was limited. In Recon2, the number of metabolic reactions is almost doubled, and therefore, its predictive accuracy is expected to be higher than previous human generic GEMs. In a recent study, Recon2 has been used to model mucopolysaccharidosis [39] . Those reactions that are linked to the deficient enzymes were blocked in the model in order to study the effect of mucopolysaccharidosis on metabolic fluxes. Using these results, the authors proposed novel biomarkers and validated some of them experimentally. It should be noted that Recon2 needs some improvements and unification in gene annotation and naming systems. The recent update of Recon2, i.e., Recon2.2, is the most comprehensive human GEM [40] . All reactions of Recon2.2 are charge and mass balanced. Recon2.2 has the most comprehensive annotation of metabolic genes and metabolites till now.
Human GEMs are also useful in achieving a better understanding of the molecular and cellular biology underlying medical issues. For example, the amount of NADPH determines the reducing power of the cell. By using Metabolic flux analysis (MFA) and Recon1, a new role for folate metabolism in generating metabolic reducing power was suggested [41] (see Appendix G for more details on MFA). The authors confirmed this role by knocking-out methylenetetrahydrofolate dehydrogenase genes experimentally, which led to the reduction of NADPH amount in the cells.
As a result of unknown metabolic information or errors in model reconstruction, some reactions may be missed from a metabolic network model. These missing reactions are called gaps. The presence of gaps can cause inconsistencies between predictions of the metabolic models and experimental data of phenotypic features of a cell. Such inconsistencies can pinpoint where metabolic knowledge is incomplete, and thus, help us in finding the missing reactions and pathways. The process of finding these missing reactions and adding them to the metabolic network is called gap filling. In two consecutive studies, new data regarding gluconate metabolism in humans were predicted during gap filling of Recon1, which were later confirmed in wet lab [42, 43] . Similarly, novel human metabolic functions regarding the fate of some metabolites in the cell, including ADP-mannose and iduronic acid, have been proposed by analyzing the blocked reactions and the gaps in Recon1 [44] .
Another possible application of human GEMs is the mapping of omics data on the network [45] , in order to understand the important activated or inactivated parts of cell metabolism. For example, Deo et al. [46] mapped metabolome data on Recon1 to reveal the diversity of affected pathways in patients' responses to glucose tolerance tests. In one study, Zelezniak et al. [47] mapped the transcriptome of type II diabetic skeletal muscle on Recon1 to find some novel biomarkers. In another study, in order to better understand the metabolic perturbations in Alzheimer's disease (AD), transcriptome and proteome data of AD-patients were mapped to Recon1 [48] . In the mentioned study, new AD-related metabolic impairment, e.g., in carnitine shuttle and folate metabolism, were revealed. The authors also proposed novel sets of biomarkers and drug targets for AD.
In reality, as a result of cell differentiation, a wide variety of human cell types exist, each with a specific transcriptome, proteome, and metabolome. Consequently, each of these cell types has its specific active metabolism. Using a generic human GEM instead of a cell-specific metabolic model may result in wrong conclusions, as some pathways are essentially inactive in a special kind of differentiated cell type while being active in another cell type. In other words, using both kinds of models may potentially generate corrects results; however, generic genome-scale models have additional reactions which are inactive in certain tissues. Such additional reactions can increase the possibility of wrong predictions, for example in finding the essential genes. Consequently, cell-and tissue-specific models are expected to generate more accurate predictions. One may integrate cell-specific metabolic networks into a larger ''multi-cellular" model to simulate the complex cellular metabolic interactions (see below).
Cell-specific metabolic networks
As we mentioned, tissue-or cell-specific metabolic network models are required for accurately predicting the metabolic behavior of the cells. There are two main strategies for cell-and tissuespecific metabolic network reconstruction. In ''ab initio" reconstruction, a bottom-up strategy is used. Briefly, a list of genes and reactions, which are known to be invariably active in a certain tissue or cell type, are collected as a core metabolic network. In order to reconstruct the complete model, some other reactions, e.g., exchange and transport reactions, are then added to the core model [49] . On the other hand, one may perform a ''reductive" reconstruction strategy to obtain cell-specific models. In this strategy, one starts with a generic GEM (e.g., Recon1) and excludes those reactions that are known not to be active in that cell type.
The exclusion of inactive reactions is usually based on cell-specific transcriptome data, like what is done by MBA [50] , GIMME [51] and mCADRE [52] , or based on cell-specific proteome data, like CORDA approach [53] . Furthermore, INIT [35] and tINIT [54] algorithms use cell-specific proteome and metabolome data, in addition to transcriptome data, for the identification of inactive reactions and pruning the generic network.
In principle, the top-down strategy is more convenient compared to the ab initio reconstruction strategy. In both cases, the output of these algorithms has to be manually curated in order to be fully functionalized. In other words, a tissue-specific metabolic model has to be curated in order to be able to accomplish the specific metabolic functions of that tissue type, e.g., the production or consumption of a certain amino acid. For example, Jebry et al. reconstructed a liver metabolic network using MBA algorithm [50] . This model was then manually curated to ensure its ability for performing hepatic functions, e.g., the conversion of ammonia to urea.
If the ''omics" data of whole tissue or organ (like heart or liver) has been used in model reconstruction, the result can be referred as a tissue-specific model. On the other hand, a cell-specific model should be reconstructed based on the omics data of an isolated cell type obtained by methods like laser capture microdissection or flow cytometry. The number of such cell-specific models is relatively low, as the omics data are usually obtained from a certain tissue/organ with mixed cell types. It should be noted that there are some models which are implicitly introduced as ''cellspecific", but the omics data of whole organ/tissue is used in their reconstruction. Constraint-based analysis of both cell-and tissuespecific metabolic network models have been proven to be useful in biomedical research, e.g., for predicting biomarkers and drug targets or studying metabolic pathways (Fig. 2) .
It should be noted that using human generic GEMs instead of cell-specific models will not necessarily generate incorrect results.
For example, in Section 2.1 we mentioned a successful study of Alzheimer's disease which had used Recon1. The advantage of using cell-specific models lies in increasing the accuracy and precision of the generated results, as we will see in the application of a brain model for studying Alzheimer's disease (See below). A potential disadvantage of cell-specific models can be the dependence of their reconstruction on the available knowledge of specific reactions and enzymes of the cell type.
In the rest of Section 2.2, and also in Table 1 , we have categorized the human metabolic network models according to the organ of tissues or cells for which these networks are reconstructed. Then, in Section 2.3, we will assess the integration of these cellor tissue-specific models. Finally, we will describe some of the biomedical applications of non-human metabolic network models.
Liver
The liver is the main center for metabolizing different chemicals in the body. Dysfunction of liver plays an important role in many human diseases, including fatty liver disease and steatohepatitis [69] . Accordingly, a number of studies have focused on reconstruction and analysis of liver metabolic network models (see [75] ).
Yang et al. [57] reconstructed a medium-scale metabolic network of hepatocytes. This network was used to model the behavior of hepatocytes in a bioartificial liver, and to fine-tune medium composition for optimal cell growth. Using this model, they predicted a concentration for each metabolite in the culture media for optimal growth [57] . Later, the designed growth medium composition was successfully tested in vitro [76] . Another mediumscale metabolic model of hepatocyte was used to study the changes of metabolic fluxes after a skin burn [58] . Metabolic flux analysis (MFA) was used to determine the effects of skin burns on metabolic fluxes (see Appendix G for more details on MFA). By comparing the MFA results of moderate skin burns with severe ones, it was revealed that gluconeogenesis pathway was inhibited Fig. 2 . Constraint-based analysis of human genome-scale metabolic network models has several biomedical applications. The main biomedical applications of human celland tissue-specific metabolic network models are predicting biomarkers and drug targets for different diseases and analyzing metabolic pathways (e.g., finding the upregulated pathways in cancer or diabetes).
in the moderate burns, while in the severe burn the flux of this pathway was increased. This study demonstrated that the metabolic response is not directly related to the level of injury.
HepatoNet1 [55] is a carefully reconstructed and manually curated liver model. This model was successfully used for simulating liver functions. In other words, the authors used 422 metabolic functions of the liver, e.g., the biosynthesis of creatine and triglyceride, as the objective function of FBA and successfully found a possible flux distribution for each case. Additionally, the authors made a list of enzymes that in case of removing the reaction(s) catalyzed by each enzyme from the model, at least one of the liver functions cannot be simulated using the model anymore. Then, they proved that the listed enzymes have been reported in the literature to cause clinical symptoms [55] . In another study, by analyzing HepatoNet1 with FBA, 38 inborn errors of metabolism that affect liver were assessed [56] . The flux distribution of normal state was compared to the diseased (gene knock-out) state in order to identify the biomarkers. Most of the biomarkers were validated using previously known experimental data.
Later on, a more complete genome-scale metabolic model of liver, iHepatocytes2322, with 7930 reactions was reconstructed [59] . Using this model and transcriptome data of non-alcoholic steatohepatitis patients, the affected metabolites and fluxes were revealed.
Heart
Dysfunction in mitochondrial metabolism is of crucial importance in heart diseases [77] . Accordingly, metabolic network of cardiac myocyte mitochondrion has been the subject of several biochemical modeling studies. Pathway analysis on this network revealed that the ATP production is more robust than heme production in mitochondrion [15] (see Appendix E for more information on metabolic pathway analysis). The effects of diabetes, ischemia, and diet on mitochondrial metabolic fluxes have also been studied [78] . Later, Jamshidi and Palsson [79] , using the same metabolic network model, showed that SNPs (Single-Nucleotide Polymorphisms) which are related to reactions with correlated fluxes are linked to the same phenotypes. The mentioned network was also helpful in identifying critical genes and reactions in hypoxia tolerance in the human heart [80] .
The response of each patient to different cardiac treatment methods was shown using another small-scale cardiac mitochondrial metabolic network and the patients' fluxome data [81] . Assuming that failing myocytes would like to maximize ATP production, ATP synthesis flux was chosen as the objective function of FBA. The fluxome data was used to constrain the flux bounds in FBA. It was shown that the patients with less response to cardiac therapy have higher flux of ATP synthesis. Therefore, it is possible to predict a patient response to the cardiac therapy by using fluxome data and the metabolic model.
Recently, a large-scale metabolic network model of heart cells [60] was reconstructed using transcriptome and proteome data. The model was used for predicting biomarkers and drug targets of cardiovascular diseases. The loss of function mutation in cardiovascular-related genes may change some of the metabolic fluxes. Furthermore, variations in the exchange fluxes, predicted by FVA, can alter the concentration of some of the extracellular metabolites. Therefore, some metabolites can be identified as [61] . CardioNet has fewer metabolites and reactions than previous heart model, while more metabolic functions of a heart cell, e.g., biosynthesis of ceramide, can be correctly simulated using CardioNet. Using CardioNet, it was shown that how changing the consumption rate of some metabolites can influence the flux of cardiac metabolic pathways, including maintenance of ATP and biosynthesis of important phospholipids.
Kidney
Chang et al. [62] reconstructed a medium-scale metabolic network model of kidney cells using two sets of transcriptome data. This model helped in revealing the metabolic side effects of a drug named torcetrapib. This drug had been developed to increase HDL and decrease LDL. It was withdrawn from phase III clinical trials because of its adverse side effects, including fatal hypertension. In this study, the metabolic enzymes which were the off-targets of torcetrapib were removed from the model to determine those metabolic fluxes and pathways which are influenced. This way, the side effects of torcetrapib were predicted. In this case, the authors suggested that if the kidney metabolic network had been reconstructed and analyzed before performing empirical experiments, it could have saved an enormous amount of time and capital investment.
In another study, a larger kidney GEM was reconstructed and used to predict biomarkers of kidney diseases [63] . By merging the latter model to the medium-scale kidney model of Chang et al. [62] , a new kidney model was recently presented to study a nephrotic disease called focal segmental glomerulosclerosis [64] . The diseased state was modeled by constraining some of the fluxes of the merged model according to the literature data. Comparing sampling and FVA data of the diseased and healthy state of the model, they found out the perturbed metabolic pathways in this disease.
Immune cells
Metabolism influences the physiology of all cells, including immune cells. For example, metabolic syndromes like obesity promote chronic inflammatory state in the body [82] . In order to study such relations, the immunometabolism field has been emerged [83] . Macrophage has a major role in the innate immune system [84] . The first metabolic model of macrophage was actually a non-human (murine) model [85] . In order to reconstruct a draft metabolic network for murine macrophage cells, Recon1 ENTREZ geneIDs were changed to murine, using NCBI HomoloGene database [85] . The analysis of this model shed light on the role of metabolism in activation of immune system. The FBA results for the fluxes of NO and ATP synthesis, and also cell growth rate, in macrophage model had better analogy than Recon1 with in vitro results. To study macrophage activation, its transcriptome, proteome, and metabolome were monitored during stimulation with LPS, an immunogenic component of the cell wall of gram-negative bacteria. In addition, the proteome data of macrophage infection with Salmonella typhimurium were compared with in silico results of flux sampling analysis and sensitivity analysis (with the help of reporter metabolites). The results of this study were in accordance with a further literature search. The interaction of Mycobacterium tuberculosis and macrophage have also been analyzed using metabolic models [86] , which is discussed in human pathogens section.
Recently, a genome-scale metabolic model of CD4 + T cells, CD4T1670, has been reconstructed [67] . CD4 + T cells, a subset of lymphocytes, are a major component of the adaptive immune system [87] . The authors modeled glucose and glutamine depletion by constraining their exchange fluxes. Then, by using random sampling of the flux space, they analyzed the depletion effects on metabolic pathways. Additionally, knock-out of immunometabolic genes was modeled in silico, in order to see the consequences on metabolic fluxes. They found out that 25% of immunometabolic genes are essential, which highlights the importance of metabolism in shaping immune responses.
Erythrocyte
Metabolism of red blood cells is mostly contained of the basic classical pathways and so, because of simplicity, the metabolic model of red blood cells has been the subject of metabolic pathway analysis (MPA) studies [88, 89] (see Appendix E). iAB-RBC-283 is the latest erythrocyte model [66] manually pruned from Recon1 using proteome data. The authors assessed a comprehensive list of drug targets and morbid SNPs to choose erythrocyte-related genes and enzymes. Then, the perturbed exchange reactions in each case of the morbid SNPs or drugs were revealed using FVA. Before this GEM, hemolytic anemia was studied using a smaller erythrocyte model [90] in an enzymopathy study. The enzymopathy was modeled by restricting the maximum allowable flux of the reaction that is catalyzed by the impaired enzyme. Then, using sampling data (see Appendix H), the affected parts of the cell metabolism in an enzymopathy were revealed.
Adipocyte
Adipose tissue is the main energy storage part of human body. The proper coordination of adipose tissue with other tissues is essential for a healthy metabolic status of the human body [91] . A fully functional and manually curated metabolic model of adipocytes with 6160 reactions has been reconstructed [49] . By mapping transcriptome data on this model, obesity-specific metabolic features were identified, like increased androsterone and keratan sulfate metabolism.
Enterocyte
In the human body, absorption of nutrients occurs mainly in the small intestine. A metabolic model of small intestine enterocyte has been manually reconstructed [69] . Different diets were simulated in the model by imposing constraints on the exchange fluxes. The changes of different metabolic fluxes that are occurred in 103 enzymopathies were also predicted using the model.
Blood vessel
The inner layer of blood vessel is composed of endothelial cells (ECs). Increased EC permeability causes excessive extravasation of plasma proteins, which occurs in many diseases [92] . In a recent study, the proteome data of human umbilical vein ECs were mapped to Recon2, in order to predict the metabolic fluxes [68] . The authors discovered the metabolic changes that lead to increased EC permeability, e.g., inhibition of CPT1A enzyme and decreasing fatty acid oxidation.
Platelet
Using MBA to have an initial draft, a metabolic network model for platelets has been reconstructed recently [71] . The model was originally generated by MBA algorithm, and then curated further using proteome data and literature. The enzymes of the model were found to be linked to 403 diseases and 231 FDA-approved drugs. By changing the bounds of certain exchange fluxes, aspirin resistance state was simulated in the platelet model, using sampling data. The effect of aspirin resistance on platelet internal metabolic fluxes was elucidated, which can be used to have a better understanding of pathophysiological conditions like coagulopathies.
Muscle
The metabolism of muscle cells is perturbed in many human diseases, including type 2 diabetes (T2D) and insulin resistance (IR) [93] . A metabolic model can be used for in silico modeling of such metabolic perturbations. In other words, a gene knockdown can be modeled by limiting flux boundaries which are related to that gene. Using FBA results of a muscle cell metabolic model, the gene knock-downs that can reproduce most of the key IR phenotypes in silico, like reduced ATP production, were suggested [73] . The results were validated using omics data of healthy and diseased states.
Recently, a genome-scale metabolic model for skeletal myocyte has been reconstructed [72] , with 5590 reactions, using tINIT algorithm. By mapping transcriptome data to this model, the metabolic signature of T2D was characterized, e.g., the decrease in the metabolism of pyruvate and tetrahydrofolate in T2D patients.
Cancer cells
Modeling cancer metabolism has recently become a popular application of metabolic networks [94] . Cancer drug targets can be predicted based on generic [95, 96] or tissue-specific models [97, 98] . Using GEMs of the NCI-60 cells, important genes for decreasing the Warburg effect were predicted [99] . Subsequently, in vitro silencing of 13 (out of 17) predicted genes were shown to inhibit the cancer cell migration. Similarly, two tissue specific cancer metabolic models have been used for predicting essential genes for the growth of each cell type [100] . Metabolic networks are also highly effective in identifying synthetic lethal interactions. This feature can help to design more efficient drug targets [101, 102] .
In a very recent study, the existence of ''antimetabolites" in metabolic networks were investigated [103] . Antimetabolites are those metabolites that can stop the growth of cancer cells, while not toxic for normal cells. In this study, reconstruction and analysis of 11 cell-line-specific GEMs led to the identification of 60 antimetabolites, one of them experimentally validated [103] . In another recent study, potential oncometabolites (i.e., metabolites with altered concentrations in cancer cells) have been predicted [104] . Furthermore, by comparing the metabolic models of drugsensitive cancer cells versus drug resistant ones, it is possible to study the metabolic causes of drug resistance [105] .
Cancer advancement process in the body could be visualized through its effects on metabolic pathways. For example, Jerby et al. defined a score for each metabolic pathway, in order to predict metabolic phenotype, using CBM to find the optimum fit between transcriptome data and flux distribution of a human metabolic model [106] . Recognizing the special metabolic changes of each stage can help in adopting more effective cure strategy.
Cell lines have various biomedical applications, from the pharmaceutical industry to cell biology researches. For example, Chinese hamster ovary (CHO) cells have a significant role in recombinant protein production [107, 108] . A metabolic model of CHO cells has been used in a metabolomics study to characterize the metabolic behavior of CHO cells during growth and nongrowth phases [109] . In another example, a metabolic network model for Human Embryonic Kidney (HEK) cells has been reconstructed [65] . HEK cells are useful in the cell and molecular researches because they are easy to handle and have a high rate of cell transfection [110] . HEK metabolic model was used to study the internal metabolic fluxes, in order to find the dominant pathways in cell growth [65] .
Stem cells
Stem cells are self-renewable cells with the ability of differentiation [111] . Adult stem cells exist in most tissues of the body [112] . These cells are valuable in regenerative medicine and tissue engineering.
In a study, using a small-scale metabolic model of mouse embryonic stem cells, the effects of different culture conditions on metabolism was assessed [113] . However, the metabolic network model of human adult stem cells has been reconstructed only very recently [70] . This genome-scale model was used for dynamicFBA [114] (i.e., for performing several consecutive FBA), in order to predict changes in the concentration of cell culture medium components, both in dynamic and static cultures.
Sperm cells
Recently, using whole-proteome data, a metabolic model of sperm cells have been reconstructed [74] . This model was used to study a specific type of male infertility caused by low sperm motility, called asthenozoospermia. The effects of previously known mutated genes of asthenozoospermia on the fluxes of all reactions of the model were studied and validated by literature data. In addition, 11 novel genes associated with sperm energy metabolism were identified by exploring the impact of in silico knock-out of genes on ATP production flux.
Brain
The brain is composed of several cell types, including neurons and astrocytes. As a result, the metabolism of brain has been mostly modeled by multi-cell-type metabolic networks (which will be discussed in the next section). In this regard, the metabolic consequences of deficiencies of two autism-related genes were assessed using FVA of a mitochondrial metabolic network [115] .
Multi-tissue and multi-cell-type metabolic networks
Most of the human diseases have symptoms that take place in more than one part of the body. In order to have more realistic simulations of diseases, multi-tissue metabolic network models are needed. For instance, adipocyte, monocyte, and hepatocytes metabolic networks (and a blood compartment to balance protons) were integrated in order to model human body [116] . In other words, the integrated metabolic model consists of three supercomponents (three metabolic models), among which some new exchange reactions are defined to link these components. By changing flux boundaries of the integrated model, it is possible to simulate Cori and glucose-alanine cycles in fasting state and also the absorptive state of the human metabolism. By mapping two sets of transcriptome data to the model, active pathways in normal versus diabetic obesity were studied.
A small-scale brain network [117] of astrocyte and neuron cells was used to depict the effects of cerebral hypoxia on fluxes of different reactions. Minimum Optimization of Metabolic Adjustment (MOMA) [118] helps in finding the new state of a network after exerting a special change, e.g., a gene knock-out (see Appendix F). MOMA was used in the latter study of brain metabolic model to study the effects of hypoxia on metabolic fluxes. In the same year, Occhhipinti and coworkers developed a small-size brain network to investigate the biochemical pathways involved in brain energetics [119] . They used random sampling of the flux space, together with a modified version of FBA, called statistical flux balance analysis, in order to test several hypotheses about fuel supply of brain metabolism. For example, they observed that the oxidative phosphorylation in a neuron is not sensitive to glucose uptake. Recently, a medium-scale two-compartment brain metabolic model has been reconstructed, which includes 570 genes and 630 metabolic reactions in astrocytes and neurons and the exchange reactions between these two compartments [120] . Using transcriptome data and gene-protein-reaction relations of the model, the authors evaluated the metabolic states of six neurodegenerative diseases with the aim of elucidating common and specific metabolic features of the diseases. In order to model Alzheimer's disease, the integration of GEMs of astrocyte and 3 types of neurons (glutamatergic, GABAergic and cholinergic neurons, plus a blood compartment and an interstitial space) formed an in silico metabolic model of the brain organ [121] . Some enzyme deficiencies of neurons are known to be associated with Alzheimer's disease [122, 123] . However, some types of the neurons can resist these deficiencies and stay healthy. Histopathological images of a diseased brain can show healthy and affected parts [124] . Such images can be used for obtaining sections of healthy and affected tissues in order to obtain tissuespecific gene expression data. By mapping transcriptome data of healthy or affected neurons to the brain model, in addition to in silico sampling data, the flux distribution of the model can depict what is happening in the metabolism of rescued neuron.
Modeling metabolic networks of human pathogens and microbiota
Both pathogenic and commensal bacteria have significant roles in our health. Here, we will have a review on metabolic networks of human pathogens and microbiota, emphasizing on the contribution of these models to biomedical research.
Microbiota
The number of microorganisms in the human body exceeds the number of its own cells. The role of human gut microbiome in prevention and also treatment of some diseases has been proven experimentally [125] .
The main phyla in the human gut are Bacteroidetes, Firmicutes, and Euryarchaeota [126] . In one of the first attempts to model the bacterial interactions in the gut, the GEM of one of the key species in each phylum was reconstructed [127] . Different sets of the three mentioned bacteria were used to represent different gut ecosystems. In order to predict the metabolic changes in each gut ecosystem, the metabolic model of each bacterium was used. Changes in the production or consumption rate of some metabolites in each gut ecosystem were predicted by flux analysis. Finally, a germfree mouse was infected with each bacterial set and was used for experimental validation of the predicted computational results.
The metagenomic data of human microbiota have been used for metabolic reconstruction of human ''community-level" microbiome [128] . As a result, it is possible to study commensal microbial metabolism directly from sequencing reads. The drawback of this model is the lack of ''boundaries" for each microbe-specific metabolic network [129, 130] . In another study, the metabolic network of Bacteroides thetaiotaomicron, a human commensal gut microbe, was integrated into the metabolic network of mouse [131] . They investigated the effect of diet on cross-feeding and competitive interaction of host and commensal microbe, by changing flux boundaries and using FVA. They also showed that some of the host lethal enzymopathies can be compensated by the metabolism of commensal microbes. The metabolic models of microbiota have been also suggested to be useful in assessing the effects of probiotics and prebiotics on human health [132] .
Human pathogens
Many GEMs have been reconstructed for various human pathogens [129] . These networks have been used to predict new drug targets [133, 134] , to study pathogenicity, virulence, and drug susceptibility [135] and to explore metabolic changes during infection [136, 137] .
The interaction between pathogen metabolism and human metabolism is another interesting field of study. For instance, the metabolic network of malaria pathogen (Plasmodium falciparum) inside erythrocyte has been reconstructed [138] . This model, together with HepatoNet1, was used to study the selectivity of 48 antimalarial drug targets [139] . In silico deletion of 24 drug targets (genes) was shown to be essential for the parasite, not human cells. In a different study, integration of Mycobacterium tuberculosis metabolic network in phagosome compartment of a macrophage model was used to simulate infection [86] . By mapping transcriptome data, the active metabolic pathways during three states of infection were found. Furthermore, mapping the transcriptome data of latent, pulmonary and meningeal tuberculosis on this model led to a better prediction of the differences among these three states of infection, and hence, better drug targeting. In a recent study, Hepatitis C virus infection has been modeled by integration of virus assembly reactions into a liver model [140] . By using transcriptome data and flux analysis of the model, the metabolic alternations in different stages of Hepatitis C virus infection, from cirrhosis to hepatocellular carcinoma, were simulated. The results of this study were validated by metabolome data and also some drug targets were proposed for Hepatitis-caused liver disorders.
Concluding remarks and future work
It is good to note some of the limitations of metabolic modeling. The first limitation is that gene regulatory and signaling pathways, in addition to kinetics, cannot be readily incorporated into metabolic networks. Although there are some efforts in this regard, such as SR-FBA [141] , but these methods have only been used in Escherichia coli and Saccharomyces cerevisiae because a comprehensive regulatory data of human cells is not currently available. The second limitation is that the concentration of an enzyme can constrain the flux bounds of the reaction(s) it catalyzes, but we neglect such constraints in metabolic modeling. Recently, new methods have been developed to integrate quantitative proteome data with GEMs, but to the best of our knowledge, this is yet to be done for human GEMs [142, 143] . The third limitation is about choosing an appropriate objective function for human context-specific models, which is still a controversial subject [144] , as, in contrast to unicellular organisms, the biological aim of human cells is not as simple as reproducing themselves. Some specific objective functions have been suggested for kidney and liver [55, 62] , but finding a relevant objective function for each tissue and cell type is still an open question.
In biomedical research, the ultimate goal is typically finding new drugs and drug targets via understanding the mechanism of diseases. Reliable GEMs can be very helpful in this aspect of biomedical research, where experiments are generally expensive. Using reliable GEMs, one can try to predict the outcome of experiments, in order to choose only the most promising experiments to be done in vivo/in vitro. This can help in diminishing the costs of biomedical research. For instance, one can compare normal models to abnormal ones, i.e., cancer or stem cell models, in order to characterize their key metabolic features for their transformation to normal ones. For example, identifying cancer-specific secreted metabolites trying to match them with normal states [35] or identifying responsible genes for stem cell transformation to a differentiated state and designing an effective genetic engineering experiment. The latter is possible by metabolic transformation algorithm (MTA) which has successfully predicted lifespanextending genes in aging (transformation of old to young state) [145] .
Altered metabolism of cells can occur in several human physiological processes, such as bone remodeling, wound healing, inflammation and infections. Metabolic networks, together with omics data, can potentially be used to model these complex processes to find more efficient treatments and drug targets. For example, sepsis [146] , which is the severe response of the human body to infection and can be life-threatening, has no specific treatments [147] . It has been shown that permeability and metabolism of endothelial cells are altered in sepsis [148] . In addition, some of the cytokines, like interleukin-6, are increased in sepsis [149] . It is expected that by elucidating metabolic effects of interleukins on endothelial metabolism, new therapeutic strategies are found to restore impaired metabolic functions of endothelium in sepsis.
When the body encounters a major injury, the whole body metabolism will be affected. In addition to repairing skin, muscle and other tissues, metabolic functions of human cells have to be restored during wound healing. Metabolic modeling of wound healing can be proposed as a prosperous interest to be worked on.
Multi-cell-type modeling can also be used for modeling bone metabolism. Osteoblasts secret calcium and other minerals [150] . When osteoblasts become trapped in the bone matrix, they differentiate into osteocytes. Osteocytes help in sensing bone load, wherein low loading conditions, osteoclasts resorb bone tissue [151] . This process is called bone remodeling. Disorders of this process occur in several diseases [152] . Therefore, bone metabolism can be an interesting subject of metabolic modeling.
Currently, many of the studies that consider GEMs focus merely on the metabolic network. One possible strategy to improve the predictive power of these models is to integrate pharmacokinetic models [153] , protein structure models [154] , signaling networks [155] or regulatory networks [156] [157] [158] with GEMs to obtain a more comprehensive understanding of metabolism. Whole-cell modeling of cell physiology is another promising aspect of GEMs [159, 160] . Such models are believed to be able to include data from different omics-scale sources in a unifying framework, although their application might be currently limited to microbial metabolic modeling, due to computational limitations. Reconstruction of such a model for human cells will enable us to understand not only the metabolism of cells but also the complete physiological properties of human cells, potentially in a multi-scale multi-tissue model [161] . It is expected that using organ-specific models as building blocks of a whole-body model of human, disease development or drug side effects can be better investigated, in order to improve human health.
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We confirm that the manuscript has been read and approved by all named authors and that there are no other persons who satisfied the criteria for authorship but are not listed. We further confirm that the order of authors listed in the manuscript has been approved by all of us. In Fig. A1 .A, a small metabolic system is illustrated. The system includes 6 reactions. Two of the reactions, r 1 and r 2 , are internal reactions. The rest of the reactions, r 3 -r 6 , are boundary reactions. The first reaction, r 1 , consumes 1 mol of metabolite A and produces 1 mol of metabolite B. The second reaction, r 2 , consumes 1 mol of metabolite B and 2 mol of metabolite C to produce 3 mol of metabolite D. These numbers are the stoichiometric coefficients of the metabolites in each reaction. Four boundary reactions, namely r 3 , r 4 , r 5 , and r 6 , are responsible for the exchange of metabolites AÀD. Note that only the concentrations of intracellular metabolites are considered in our modeling framework.
In Fig. A1 .A, reactions are shown either by arcs or hyperarcs. A simple reaction, conversion of a single reactant to a single product, can be shown by an arc. On the other hand, for the reactions with more than one reactant (resp. product), we use a hyperarc which has more than one reactant (resp. product). As an example, in Fig. A1 .A, reaction r 1 is represented by an arc, while reaction r 2 is represented by a hyperarc.
We have six reactions and four metabolites in our model, so we have a 4 Â 6 stoichiometric matrix (S). As mentioned in the text, element S ij represents the stoichiometric coefficient of metabolite i in reaction j (Fig. A1.B) . Changes in the concentration of each metabolite can be determined from the rate of reactions that consume or produce that metabolite. Let v j be the flux of reaction j. 
It can be shown that element _ C i is equal to the concentration change of metabolite i during the time [162, 163] . In other words, numerically. Consequently, the precise state of the metabolic system, i.e., all metabolite concentrations and reaction fluxes, can be computed precisely at any time point. However, for real-world biochemical systems, our knowledge about kinetic parameters p and also function f is very limited. Therefore, ODE modeling of largescale metabolic networks is practically impossible. In constraintbased modeling, on the other hand, we apply simplifying assumptions (e.g., steady-state assumption) to cope with this problem. By constraint-based modeling, even in the absence of detailed information, one can determine what metabolic phenotype is possible and what is not, but in contrast to the ODE modeling, we may not be able to predict the state of the metabolic system precisely [164] . See Appendix B for more details.
Appendix B. Linear constraints for constraint-based modeling of metabolic networks
B.1. Mass balance constraints
Enzyme-catalyzed reactions are generally assumed to be ''fast" compared to other cellular processes (e.g., gene regulation). Therefore, a metabolic network can be assumed to be in ''quasi-steadystate" conditions, which means that _ C ¼ 0. Thus, Eq. (1) can be written as:
The linear constraint of Eq. (3) will be referred to as the ''stoichiometric constraint". For example, for the network represented in Fig. A1 , one can easily check that w ¼ 
B.2. Thermodynamic constraints
Some metabolic reactions are reversible, i.e., they are able to work both in the forward and in the reverse directions. Other metabolic reactions are called irreversible. The flux through an irreversible reaction is either non-positive or non-negative, which can be shown as a linear constraint (called ''thermodynamic constraint"):
B.3. Capacity constraints
For certain reactions of a metabolic system, the flux upper-or lower-bound may be known. In such cases, one can consider a linear constraint (called ''capacity constraint"):
The above-mentioned constraints (Eqs. 
Appendix D. Flux variability analysis (FVA)
Flux variability analysis is a method to find a possible range of fluxes for each reaction when the objective function takes its optimal value [165] . In the first step of FVA, an FBA should be solved to find the optimal value of the objective function, Z opt . Then, for each reaction j two linear problems should be solved: FVA can be exploited for identifying reactions whose flux range changes by applying a new physiological constraint like mutation or hypoxia (Fig. A2) . In other words, FVA is done before and after applying a constraint. The flux range of each reaction can be either unchanged, moderately or considerably changed. The latter group can be used to infer new data regarding the physiological constraint. For example, in metabolic dysfunction, those secreted metabolites which are related to the considerably changed exchange fluxes can be used as potential diagnostic biomarkers [32] . In another example, comparing FVA results, before and after constraining oxygen consumption flux, revealed the hypoxia affected parts of cell metabolism [80] .
Appendix E. Metabolic pathway analysis (MPA)
In constraint-based modeling of metabolic networks, a metabolic pathway is a set of consecutive reaction fluxes. A metabolic pathway typically starts from an exchange reaction, represents a balanced conversion of reactants to products, and leads to the secretion of end point metabolite(s) via other exchange reaction (s). Elementary modes [166, 167] and extreme pathways [168] are among mathematical definitions of pathways which are proposed for being used in Metabolic Pathway Analysis (MPA). This type of analysis can be used for different purposes, ranging from metabolic engineering [169, 170] to the analysis of biochemical pathways in human cells [171] to personalized medicine [172] . The main challenge with MPA is the combinatorial explosion of the number of pathways. In other words, the number of pathways in a metabolic network may increase exponentially with the number of reactions. Consequently, the required time and memory for computation of elementary modes (and extreme pathways) limits the applicability of MPA to small-scale networks. However, a limited set of elementary modes could be chosen and studied according to the gene expression state of the cell [173] . By this strategy, MPA might be used even for genome-scale metabolic networks.
After measuring some internal and external metabolic fluxes, one can use such data to compute unknown fluxes. Assuming steady-state conditions for a network, other unknown (unmeasured) fluxes can be computed according to the following equation: MFA can also be used to validate a metabolic network or to find consequences of the cell perturbations [175] , such as specific enzyme deficiencies [176] . Unfortunately, MFA of large-scale metabolic networks is hard and time-consuming. Therefore, predicted fluxes (obtained by MOMA or FBA) are often used instead.
Appendix H. Uniform random sampling of the flux space
As mentioned in Appendix B, by applying the metabolic constraints on flux values, the possible range of each reaction flux will be limited. However, it is also important to have an overview of the distribution of reaction fluxes within their bounded range, and additionally, to find those reactions whose fluxes are correlated. By sampling the solution space such analyses will be possible [177] . Artificial Centering Hit-and-Run (ACHR) algorithm [178] is one of the various algorithms which can be used for sampling. This algorithm generates random points in the flux space. It starts with generating a matrix of warm up points. Moving toward the direction of a random vector, a new point is substituted in the matrix. With the iteration of the last step, a desired number of random flux distributions can be generated. It has to be mentioned that new algorithms have been developed for sampling in order to improve the results [179, 180] . For example, II-ACHRB is a new algorithm that can remove thermodynamically unfeasible loops from sampling results [181] .
